Gary M. Owens Sells 21,000 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CEO Gary M. Owens sold 21,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now owns 43,337 shares of the company’s stock, valued at approximately $5,369,887.67. The trade was a 32.64 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mesa Laboratories Stock Up 2.6 %

Mesa Laboratories stock traded up $3.31 during mid-day trading on Monday, hitting $128.45. The company had a trading volume of 60,584 shares, compared to its average volume of 37,028. The stock has a market cap of $698.00 million, a price-to-earnings ratio of -2.78 and a beta of 0.82. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 1 year low of $83.68 and a 1 year high of $155.12. The business has a fifty day moving average of $137.90 and a 200 day moving average of $129.18.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. On average, sell-side analysts expect that Mesa Laboratories, Inc. will post 8 earnings per share for the current fiscal year.

Mesa Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, February 28th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.50%. Mesa Laboratories’s dividend payout ratio (DPR) is currently -1.38%.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Pacer Advisors Inc. grew its position in Mesa Laboratories by 4.3% in the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock valued at $231,000 after buying an additional 73 shares during the last quarter. Berry Wealth Group LP boosted its holdings in shares of Mesa Laboratories by 5.3% in the fourth quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock valued at $219,000 after acquiring an additional 83 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Mesa Laboratories by 3.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,925 shares of the medical instruments supplier’s stock worth $386,000 after acquiring an additional 98 shares during the period. FMR LLC raised its holdings in Mesa Laboratories by 34.1% during the third quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 100 shares in the last quarter. Finally, Los Angeles Capital Management LLC raised its stake in shares of Mesa Laboratories by 3.0% during the 4th quarter. Los Angeles Capital Management LLC now owns 3,394 shares of the medical instruments supplier’s stock worth $448,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 90.60% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.